What is Aurora Cannabis?
Founded in 2006, Aurora Cannabis is a licensed cannabis producer from Canada. With a current estimated capacity of more than 500,000 kg per year, Aurora is considered one of the world’s leading and fastest-growing marijuana companies.
Aurora Cannabis works across various segments of the cannabis value chain, including genetics research, cannabis breeding, home cultivation, retail and wholesale distribution of medical marijuana.
With a growing network of subsidiaries and strategic partnerships, Aurora Cannabis operates in 19 countries across five continents. Today, as the number of countries legalising the use of medical cannabis is rapidly growing, the company has embarked on an aggressive international expansion strategy, resulting in sales and operations in Denmark, Italy, Germany and Australia.
The product range of Aurora Cannabis includes cannabis oil and dried cannabis, hemp products and CanniMed vegan capsules. Aurora also sells vaporizers, consumable vaporizer accessories, and herb mills for using herbal cannabis products.
Aurora Cannabis trading hours
ACB shares are traded on the Toronto stock exchange (TSX) according to the regular trading session schedule from 9:30 to 16:00(GMT-05:00). Aurora Cannabis shares are also traded on the NYSE according to the following trading hours:
- Pre-Market trading hours from 4:00 to 9:30
- Market hours from 9:30 to 16:00
- After-Market hours from 16:00 to 20:00
If you choose to trade CFDs, you can follow the Aurora Cannabis share price live in US dollars with the comprehensive Aurora stock chart on Capital.com:
- Monday to Friday from 14:30 to 21:00
How to trade Aurora Cannabis shares?
An individual has two options when trading in the stock market. Firstly, they can buy shares in companies on the exchanges where they are listed. For instance, you can invest in ACB shares on the TSX and NYSE, so you actually own a share in the company. This can be considered a long-term investment, as the individual is usually waiting for the price to rise over time.
Alternatively, they can trade a contract for difference (CFD) on a particular marijuana stock, and speculate on the ACB share price difference, without actually owning the asset. A CFD is a financial contract, typically between a broker and an investor, where one party agrees to pay the other the difference in the value of a security, between the opening and closing of the trade. You can either hold a long position (speculating that the price will rise) or a short position (speculating that the price will fall). This is considered a short-term investment or trade, as CFDs tend to be used within shorter timeframes.
The key difference between trading a long position with a CFD and buying a security is the leverage that is employed. CFDs are traded on margin, which means that a trader can open larger positions with their capital.
Why trade ACB CFDs with Capital.com
Advanced AI technology at its core: A Facebook-like News Feed provides users with personalised and unique content depending on their preferences. If a trader makes decisions based on biases, the innovative News Feed offers a range of materials to put him back on the right track. The neural network analyses in-app behaviour and recommends videos, articles, news to polish your investment strategy.
Trading on margin: Providing trading on margin (up to 5:1 for individual equities), Capital.com gives you access to the stock market with the help of CFDs.
Trading the difference: When trading an ACB CFD, you don’t buy the underlying asset itself, meaning you are not tied to it. You only speculate on the rise or fall of the ACB share price. CFD trading is nothing different from traditional trading in terms of strategies. A CFD investor can go short or long, set stop and limit losses and apply trading scenarios that align with their objectives.
All-round trading analysis: The browser-based platform allows traders to shape their own market analysis and forecasts with sleek technical indicators. Capital.com provides live market updates and various chart formats, available on desktop, iOS, and Android.
Focus on safety: Captal.com puts a special emphasis on safety. Licensed by the FCA and CySEC, it complies with all regulations and ensures that its clients’ data security comes first. The company allows to withdraw money 24/7 and keeps traders’ funds across segregated bank accounts.
History of Aurora Cannabis
Aurora was founded in 2006 by Terry Booth, Dale Lesak, Steve Dobler
and Chris Mayerson in Canada. The founders secured over 160 acres of land in Mountain View County – the first Aurora facility.
In 2014, the company received a license to grow and sell medical cannabis and became the first official cannabis producer in the area. Later on, Aurora Cannabis built several growing facilities across the country and also in Europe.
In July 2017, following its graduation from the TSX Venture Exchange, Aurora Cannabis stock started trading on the Toronto Stock Exchange. The company doubled the number of registered patients and tripled its monthly revenue. With a growing international expansion in Germany and Australia, the company increased its market capitalisation by more than $600 million to almost $950 million.
In October 2018, one of the leading marijuana stocks debuted on the New York Stock Exchange (NYSE). According to Aurora’s CEO Terry Booth, the company intends to "meet the growing demand for high-quality cannabis both in Canada and abroad".
Today, Aurora is rapidly diversifying its offering through multiple acquisitions, strategic partnerships and R&D.
As with any equity, quarterly earnings announcements, as well as the financial performance of the wider stock market are two crucial factors to watch when deciding how ACB stock will perform.
With further moves towards marijuana legalisation across the world, some investors may feel that the leading Canadian cannabis producer has potential for future growth. Remaining the 3rd largest marijuana stock in Canada, after Canopy and Tilrey, Aurora Cannabis could further solidify its position within Canada and abroad. Recently, the company has increased its EU footprint and has received approval to supply its product to Poland and Luxembourg.
With many countries finally saying YES to cannabis, marijuana stocks draw the attention of traders globally. With some viewing cannabis legalisation as just a matter of time, Aurora Cannabis and its peers may provide good trading opportunities. The three major Aurora’s competitors include:
- Canopy Growth
Together with its subsidiaries, Canopy engages in the growth, production and sale of medical cannabis in Canada.
Tirley was the first company to legally export medical cannabis from North America to New Zealand and Australia.
The company produces a range of high-quality, safe and pure medical marijuana and cannabis oil products.